Arax Advisory Partners’s Solesence Inc SLSN Stock Holding History

Arax Advisory Partners’s Portfolio SLSN Stock Details SLSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24	Closed	-$77	–	4632
2025 Q3	$77	Buy	+24	New	+$86	﹤0.01%	3513

Other funds holding SLSN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Arax Advisory Partners's SLSN Position: Q4 2025 in Review

Arax Advisory Partners sold out of Solesence Inc (SLSN) in Q4 2025, closing a stake of 24 shares — an estimated $77 sold.

Arax Advisory Partners first reported a position in SLSN in Q3 2025 and held it in 1 quarter. The position peaked at $77 in Q3 2025. 42 funds tracked by Wall St. Rank hold SLSN as of Q4 2025.

Arax Advisory Partners reported no remaining Solesence Inc position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 24 Solesence Inc shares in Q4 2025, an estimated $77.
Arax Advisory Partners first reported a position in Solesence Inc in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Solesence Inc position peaked at $77 in Q3 2025.
42 funds tracked by Wall St. Rank held Solesence Inc as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.